all report title image

Brain Hemorrhage Market, By Drug Type (Anti-hypertensive Drugs, Anti-convulsants Drugs, Hyperosmotic Drugs, Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 25 Jun, 2026
  • Code : CMI4659
  • Pages :253
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
  • 역사적 분포 범위 : 2020 - 2024
  • 기준 연도 : 2025
  • 예상 연도 : 2026
  • 예측 기간 : 2026 - 2033

Brain hemorrhage is a medical emergency condition wherein blood vessel ruptures and causes bleeding inside the brain. This bleeding can also occur between the brain and the membranes covering the brain, between the skull and the covering of the brain or between the membrane layers covering the brain. The blood from the ruptured blood vessel irritates the surrounding tissues of brain and causes swelling, a condition known as cerebral edema. The blood from ruptured blood vessel starts pooling into a mass inside the brain and this mass is called a hematoma. Hematoma starts building pressure on the tissues of the brain, thus reducing vital blood flow to the brain and causing brain cells to die. Brain hemorrhage is identified as a type of stroke and requires immediate treatment and care with the help of medication or brain surgery. Some of the risk factors associated with occurrence of brain hemorrhage include brain trauma, brain tumor, weak blood vessels, liver drug, hypertension, excessive smoking, hypocholesterolemia, excessive alcohol consumption drugs, and online Pharmacies.

Market Dynamics

The increasing incidence of brain hemorrhage and head injury, rising research and development activities for the development of novel therapeutics for the treatment of brain hemorrhage, and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, are the major factors that are expected to drive growth of the global brain hemorrhage market over the forecast period.

For instance, according to data provided by the Centers for Disease Control and Prevention it is estimated that around 61,000 people died due to traumatic brain injury in the U.S. in 2018, which indicates that nearly 166 deaths were caused due to traumatic brain injury every day in the U.S. in 2018, and this number is expected to increase in the near future.

Key features of the study

  • This report provides in-depth analysis of the global brain hemorrhage market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brain hemorrhage market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Baxter, Oxurion NV, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Novartis AG, Bayer AG, Abbott, Bristol-Myers Squibb, Johnson and Johnson, Neurotech Pharmaceuticals, Inc., Siemens Healthcare GmbH, Novo Nordisk A/S, H. Lundbeck A/S, and Ligand Pharmaceuticals Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brain hemorrhage market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain hemorrhage market

Market Segmentation

  • By Drug Type (Revenue, USD Mn, 2021-2033)
    • Anti-hypertensive Drugs
    • Anti-convulsants Drugs
    • Hyperosmotic Drugs
    • Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
  • By Distribution Channel (Revenue, USD Mn, 2021-2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region (Revenue, USD Mn, 2021-2033)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
  • Key Players
    • Baxter
    • Oxurion NV
    • Pfizer, Inc.
    • Hoffmann-La Roche Ltd.
    • Boehringer Ingelheim
    • Novartis AG
    • Bayer AG
    • Abbott
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Neurotech Pharmaceuticals, Inc.
    • Siemens Healthcare GmbH
    • Novo Nordisk A/S
    • Lundbeck A/S
    • Ligand Pharmaceuticals Incorporated

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. Global Brain Hemorrhage Market, By Drug Type, 2021 – 2033, (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Anti-hypertensive Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
    • Anti-convulsants Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
    • Hyperosmotic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
    • Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
  5. Global Brain Hemorrhage Market, By Distribution Channel, 2021 – 2033, (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
  6. Global Brain Hemorrhage Market, By Region, 2021 – 2033, (USD Million)
    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Baxter
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Oxurion NV
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Pfizer, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Boehringer Ingelheim
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Abbott
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Bristol-Myers Squibb
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Johnson and Johnson
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Neurotech Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Siemens Healthcare GmbH
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Novo Nordisk A/S
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • H. Lundbeck A/S
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Ligand Pharmaceuticals Incorporated
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.